Massachusetts General Hospital Cancer Center, 55 Fruit Street, Boston, MA, 02114, USA.
Outcomes4Me Inc, One Beacon St, 15th Floor, Boston, MA, 02108, USA.
Breast Cancer Res Treat. 2023 Jun;199(3):501-509. doi: 10.1007/s10549-023-06918-y. Epub 2023 Apr 27.
Patients with breast cancer (BC) face complex medical information and decisions. The Outcomes4Me mobile app provides evidence-based BC education, symptom management tracking and clinical trial matching. This study sought to evaluate the feasibility of introducing this app into routine BC care.
In this pilot study among BC patients undergoing therapy at an academic cancer center, patients were followed for 12 weeks with survey administration and electronic health record (EHR) abstraction at baseline and completion. Feasibility was defined as 40% of patients engaging with the app 3 or more times during the study. Additional endpoints included app usability (system usability scale), patient care experience, symptom evaluation, and clinical trial matching.
The study enrolled 107 patients from 6/01/2020 to 3/31/2021. Utilization of the app was deemed feasible with 60% of patients engaging with the app at least 3 times. SUS score of 70 indicated above average usability. New diagnosis and higher education level was associated with greater app engagement, with usability similar across all age groups. 41% of patients found the app helped track symptoms. Cognitive and sexual symptoms were infrequently reported, but were more frequently captured in the app than in the EHR. After using the app, 33% of patients reported increased interest in clinical trial enrollment.
Introducing the Outcomes4Me patient navigation app into routine BC care is feasible and may improve the patient experience. These results support further evaluation of this mobile technology platform to improve BC education, symptom management, and decision making.
Clinicaltrials.gov registration #: NCT04262518.
乳腺癌（BC）患者面临复杂的医学信息和决策。Outcomes4Me 移动应用程序提供基于证据的 BC 教育、症状管理跟踪和临床试验匹配。本研究旨在评估将该应用程序引入常规 BC 护理的可行性。
在学术癌症中心接受治疗的 BC 患者中进行这项试点研究，在基线和完成时通过调查管理和电子健康记录（EHR）提取对患者进行 12 周的随访。可行性定义为在研究期间至少有 40%的患者使用该应用程序 3 次或以上。其他终点包括应用程序的可用性（系统可用性量表）、患者护理体验、症状评估和临床试验匹配。
该研究于 2020 年 6 月 1 日至 2021 年 3 月 31 日期间招募了 107 名患者。有 60%的患者至少使用该应用程序 3 次，因此认为该应用程序的使用是可行的。SUS 评分 70 表示高于平均可用性。新诊断和更高的教育水平与更高的应用程序参与度相关，所有年龄组的可用性相似。41%的患者发现该应用程序有助于跟踪症状。认知和性功能症状很少报告，但在应用程序中比在 EHR 中更频繁地捕获。使用该应用程序后，33%的患者表示对参加临床试验的兴趣增加。
将 Outcomes4Me 患者导航应用程序引入常规 BC 护理是可行的，并且可能改善患者体验。这些结果支持进一步评估该移动技术平台，以改善 BC 教育、症状管理和决策制定。
NCT04262518。
